X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30) 30
index medicus (30) 30
medicine general & introductory medical sciences (28) 28
medicine, general & internal (28) 28
lungs & airways (27) 27
asthma (26) 26
randomized controlled trials as topic (25) 25
asthma - drug therapy (20) 20
adult (19) 19
child health (18) 18
child (16) 16
corticosteroids (13) 13
adrenal cortex hormones (12) 12
anti-asthmatic agents - administration & dosage (12) 12
anti‐asthmatic agents (12) 12
quality of life (12) 12
steroids, inhaled (12) 12
bronchodilators (11) 11
disease progression (11) 11
administration, inhalation (10) 10
asthma, chronic ‐ pharmacotherapy (10) 10
adrenal cortex hormones - administration & dosage (9) 9
combination and additive therapies (9) 9
combination/additive drug treatment (9) 9
female (9) 9
male (9) 9
therapy (9) 9
adrenergic beta‐2 receptor agonists (8) 8
asthma, chronic ‐ non‐pharmacotherapy (8) 8
children (7) 7
double-blind (7) 7
adolescent (6) 6
asthma, acute ‐ pharmacotherapy (6) 6
budesonide (6) 6
disease management and monitoring (6) 6
drug therapy (6) 6
education (6) 6
middle aged (6) 6
administration & dosage (5) 5
adrenergic beta-2 receptor agonists - administration & dosage (5) 5
beta‐agonists, long‐acting (5) 5
drug therapy, combination (5) 5
drug therapy, combination - methods (5) 5
exacerbations (5) 5
muscarinic antagonists (5) 5
quality-of-life (5) 5
randomized controlled-trial (5) 5
salmeterol (5) 5
administration, oral (4) 4
adults (4) 4
asthma: self‐management & education (4) 4
delivery of care (4) 4
efficacy (4) 4
emergency service, hospital (4) 4
lung-function (4) 4
magnesium sulfate (4) 4
management (4) 4
metered-dose inhaler (4) 4
other medications (4) 4
self‐management & education (4) 4
tiotropium bromide (4) 4
acute disease (3) 3
adrenergic beta-2 receptor agonists - therapeutic use (3) 3
asthma: bronchodilators (3) 3
asthma: delivery of care (3) 3
bronchodilator agents (3) 3
childhood asthma (3) 3
chronic disease (3) 3
chronic obstructive pulmonary disease, stable ‐ pharmacotherapy (3) 3
epidemiology (3) 3
hospitalization (3) 3
internet (3) 3
intervention (3) 3
magnesium sulfate - administration & dosage (3) 3
medication adherence (3) 3
methods (3) 3
muscarinic antagonists - administration & dosage (3) 3
pulmonary disease, chronic obstructive (3) 3
pulmonary disease, chronic obstructive - drug therapy (3) 3
respimat add-on (3) 3
respiratory system (3) 3
respiratory tract diseases (3) 3
safety (3) 3
self-management (3) 3
strategies (3) 3
systematic review (3) 3
telephone (3) 3
trial (3) 3
2nd-line treatment (2) 2
50 mu-g (2) 2
adrenal cortex hormones - therapeutic use (2) 2
adrenergic beta-2 receptor agonists - adverse effects (2) 2
adverse effects (2) 2
aged (2) 2
air-flow obstruction (2) 2
airway inflammation (2) 2
anti-asthmatic agents - adverse effects (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
anti‐inflammatory agents (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2014, Volume 2014, Issue 12, p. CD010115
Background Inhaled corticosteroids (ICS) are anti‐inflammatory drugs that have proven benefits for people with worsening symptoms of chronic obstructive... 
Budesonide | Pneumonia | Lungs & airways | Pulmonary Disease, Chronic Obstructive | Respiratory infections: pneumonia | Androstadienes | Administration, Inhalation | Bronchodilator Agents | Fluticasone | Randomized Controlled Trials as Topic | Steroids, inhaled | Adrenergic beta‐2 Receptor Agonists | Child health | Respiratory infections | Anti‐Inflammatory Agents | Chronic obstructive pulmonary disease, stable ‐ pharmacotherapy | Drug Therapy, Combination | Medicine General & Introductory Medical Sciences | Adverse effects of treatments | MEDICINE, GENERAL & INTERNAL | EUROPEAN RESPIRATORY SOCIETY | METERED-DOSE INHALER | FLUTICASONE PROPIONATE/SALMETEROL 250/50 | DOUBLE-BLIND | COPD EXACERBATIONS | LUNG-FUNCTION | BRONCHOALVEOLAR LAVAGE CELLS | 50 MU-G | LONG-TERM TREATMENT | HEALTH-STATUS | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Male | Drug Therapy, Combination - methods | Androstadienes - administration & dosage | Anti-Inflammatory Agents - adverse effects | Adrenergic beta-2 Receptor Agonists - adverse effects | Pneumonia - chemically induced | Budesonide - adverse effects | Adrenergic beta-2 Receptor Agonists - administration & dosage | Anti-Inflammatory Agents - administration & dosage | Female | Budesonide - administration & dosage | Bronchodilator Agents - adverse effects | Androstadienes - adverse effects | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Thorax, ISSN 0040-6376, 12/2018, Volume 73, Issue 12, pp. 1110 - 1119
BackgroundAsthma guidelines guide health practitioners to adjust treatments to the minimum level required for asthma control. As many people with asthma have... 
paediatric asthma | asthma | exhaled airway markers | pulmonary eosinophilia | MANAGEMENT | ADULTS | CHILDHOOD ASTHMA | CHILDREN | STRATEGIES | COUNTS | FRACTION | REDUCTION | RESPIRATORY SYSTEM | DOUBLE-BLIND | EXACERBATIONS | Studies | Bibliographic literature | Nitric oxide | Bias | Clinical trials | Systematic review | Inflammation | Bronchitis | Quality of life | Asthma
Journal Article
Lancet Psychiatry, The, ISSN 2215-0366, 2014, Volume 1, Issue 5, pp. 368 - 376
Summary Background Social anxiety disorder—a chronic and naturally unremitting disease that causes substantial impairment—can be treated with pharmacological,... 
Psychiatry | MODELING FRAMEWORK | THERAPY | EFFICACY | SERTRALINE | PSYCHIATRY | PREVENTION | PREVALENCE | PHOBIA | COMORBIDITY
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2014, Volume 2014, Issue 3, p. CD010844
Background Pharmacological therapy for chronic obstructive pulmonary disease (COPD) is aimed at relieving symptoms, improving quality of life and preventing or... 
Lungs & airways | DNA‐Binding Proteins | Delayed‐Action Preparations | Adrenal Cortex Hormones | Pulmonary Disease, Chronic Obstructive | Muscarinic Antagonists | Beta‐agonists, long‐acting, once daily | Beta‐agonists, long‐acting, twice daily | Nuclear Proteins | Randomized Controlled Trials as Topic | Combination and additive therapies | Steroids, inhaled | Cholinergic Antagonists | Adrenergic beta‐2 Receptor Agonists | Chronic obstructive pulmonary disease (stable) | Bronchodilators | Chronic obstructive pulmonary disease, stable ‐ pharmacotherapy | Transcription Factors | Medicine General & Introductory Medical Sciences | Corticosteroids (inhaled, oral or intranasal) | Combination/additive drug treatment | MEDICINE, GENERAL & INTERNAL | OBSTRUCTIVE PULMONARY-DISEASE | EUROPEAN RESPIRATORY SOCIETY | DAILY ACLIDINIUM BROMIDE | ONCE-DAILY INDACATEROL | FLUTICASONE PROPIONATE/SALMETEROL IMPROVES | PROVIDES SUPERIOR BRONCHODILATION | FIXED-DOSE COMBINATION | BRONCHOALVEOLAR LAVAGE CELLS | 50 MU-G | AIR-FLOW OBSTRUCTION | Humans | Middle Aged | Male | Muscarinic Antagonists - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Delayed-Action Preparations - administration & dosage | Adrenergic beta-2 Receptor Agonists - therapeutic use | Female | Cholinergic Antagonists - therapeutic use | DNA-Binding Proteins | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article